Version history

{
  "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "scidex.core.llm.complete",
  "action": "critique",
  "content": "# Critical Evaluation of Hypotheses: Neuronal Resistance to Autophagy Induction in ALS\n\n---\n\n## Hypothesis 1: Impaired TFEB/TFE3 Nuclear Translocation Due to mTORC1 Hyperactivity\n\n**Weak Links:**\n- The evidence for \"attenuated responses\" to mTOR inhibitors in neurons conflates upstream TFEB activation with downstream execution. If lysosomal function (Hypothesis 3) is the primary bottleneck, mTORC1 inhibition may successfully induce TFEB nuclear translocation without measurable autophagic flux improvement—a confounding variable that inflates the apparent importance of this mechanism.\n- Constitutive mTORC1 activity in mature neurons reflects high baseline protein synthesis demands rather than a pathological \"locked state.\" Framing this as dysregulation may be conceptually misaligned with physiological neuronal homeostasis.\n- TFEB/TFE3 show partial functional redundancy; single-factor experiments may underestimate compensatory mechanisms.\n\n**Counter-Evidence:**\n- Multiple studies report that direct TFEB nuclear translocation (via mTOR-independent pathways) is also partially ineffective in neurons, suggesting the block lies downstream of nuclear TFEB binding.\n- Conditional TFEB/TFE3/TFE4 triple knockout in neurons does not cause immediate autophagic failure, indicating substantial TFEB-independent autophagic capacity.\n\n**Falsifying Experiment:**\n- Express constitutively nuclear TFEB (S211A/S122A triple mutant) via AAV in SOD1G93A motor neurons in vivo. If autophagic flux remains impaired despite robust nuclear TFEB, the mTORC1-TFEB axis is not the primary bottleneck and this hypothesis must be downgraded to a modulatory rather than causative role.\n\n**Revised Confidence:** 0.58 (downgraded from 0.78 due to mechanistic non-uniqueness and potential downstream confounds)\n\n---\n\n## Hypothesis 2: Neuron-Specific Expression of Autophagy Inhibitory Phosphatases (PP2A/Bβ1)\n\n**Weak Links:**\n- PPP2R2B is described as \"neuron-enriched\" but not neuron-exclusive, yet the hypothesis requires this to explain cell-type specificity. Non-neuronal cells expressing PPP2R2B should exhibit similar resistance if this is the primary mechanism—unless neuronal isoforms have distinct targeting.\n- The selective dephosphorylation of ULK1-S757 over S317 lacks mechanistic clarity. How does the PP2A-Bβ1 holoenzyme distinguish between sites with similar local environments? Without structural data on the PP2A-Bβ1:ULK1 interface, this specificity is asserted but not demonstrated.\n- Elevated total PP2A activity in ALS tissue does not establish that the Bβ1 subunit is responsible for the relevant enzymatic activity.\n\n**Counter-Evidence:**\n- AMPK activators (AICAR, metformin) successfully induce autophagy in neurons in many contexts, suggesting ULK1-S757 dephosphorylation is not an insurmountable barrier. If PP2A-Bβ1 dominance were absolute, AMPK-mediated phosphorylation should be reversed by constitutive dephosphorylation.\n- The cited LB-100 study shows PP2A inhibition potentiates autophagy in cancer, not neurons—cross-tissue generalization is unwarranted.\n\n**Falsifying Experiment:**\n-",
  "tokens_used": "774",
  "persona_id": "persona-skeptic"
}